Smith & Nephew (SNN) Long-Term Deferred Tax (2009 - 2025)
Smith & Nephew (SNN) reported Long-Term Deferred Tax of $307.0 million for Q4 2025, down 3.76% on a YoY basis from $319.0 million in Q4 2024, and down 23.44% quarter-over-quarter from $401.0 million in Q2 2025.
Smith & Nephew (SNN) Long-Term Deferred Tax (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Long-Term Deferred Tax for 16 years, with the latest figure at $307.0 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax fell 3.76% year-over-year to $307.0 million; the trailing twelve-month figure through Dec 2025 stood at $307.0 million (down 3.76% YoY), and the FY2025 full-year result was $307.0 million, down 3.76% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $307.0 million, down from $401.0 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $401.0 million in Q2 2025, with the low at $177.0 million in Q4 2022.
- Historically, Long-Term Deferred Tax has averaged $284.1 million across 5 years, with a median of $307.0 million in 2025.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax surged 229.51% — and 2022, when it decreased 11.94%.
- Smith & Nephew's Long-Term Deferred Tax stood at $201.0 million in 2021, then retreated by 11.94% to $177.0 million in 2022, then jumped by 49.72% to $265.0 million in 2023, then gained by 20.38% to $319.0 million in 2024, then retreated by 3.76% to $307.0 million in 2025.
- The last three Long-Term Deferred Tax figures came in at $307.0 million (Q4 2025), $401.0 million (Q2 2025), and $319.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 307.00 Mn |
| Jun 28, 2025 | 401.00 Mn |
| Dec 31, 2024 | 319.00 Mn |
| Jun 29, 2024 | 319.00 Mn |
| Dec 31, 2023 | 265.00 Mn |
| Dec 31, 2022 | 177.00 Mn |
| Dec 31, 2021 | 201.00 Mn |
| Dec 31, 2020 | 61.00 Mn |
| Jun 30, 2020 | 224.00 Mn |
| Dec 31, 2019 | 150.00 Mn |
| Jun 29, 2019 | 134.00 Mn |
| Dec 31, 2018 | 126.00 Mn |
| Jun 30, 2018 | 129.00 Mn |
| Dec 31, 2016 | 97.00 Mn |
| Dec 31, 2015 | 105.00 Mn |
| Jun 30, 2015 | 75.00 Mn |
| Dec 31, 2014 | 77.00 Mn |
| Sep 30, 2014 | 90.00 Mn |
| Jun 28, 2014 | 84.00 Mn |
| Mar 31, 2014 | 134.00 Mn |